Building Medtech Connections and Why They Matter
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Coverage & Payment
Learn more about our Payment & Health Care Delivery Policy work.
New AdvaMed Report Finds Critical Need for Enhanced CMS Resources
AdvaMed, the Medtech Association, released a new report, done in collaboration with Health Management Associates, that highlights the need for new resources to support the work of the Coverage and…
Medicare Coverage Processes: An Analysis of Procedural and Resource Concerns
This report focuses on coverage for devices and issues related to procedural delays, the lack of transparency in Medicare’s National Coverage Determination process, the use of Coverage with Evidence Development,…
AdvaMed Announces Carol Blackford to Lead Association’s Payment Policy Department
Today, AdvaMed, the Medtech Association, announced that Carol Blackford has joined the organization as Executive Vice President of Payment and Health Care Delivery Policy. She will lead the AdvaMed team…
Coverage of Breakthrough Technologies at Center of New House Committee Hearing
This week, AdvaMed, the Medtech Association, praised ongoing legislative efforts to develop a pathway for Medicare coverage for FDA-approved breakthrough technologies during a House Committee on Energy and Commerce Subcommittee…
AdvaMed Statement on CMS’s Proposed Rule for Breakthrough Technology Coverage
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recently issued proposed Transitional Coverage for Emerging Technologies (TCET) rule.
AdvaMed Position Statement Regarding Transition to National Reimbursement Codes
This AdvaMed position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Medtech Coverage, Coding and Reimbursement 101 and 201 Workshops
Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…